Pharmaco-Capitalism: The Financialization of Chronic Cellular Disease

The publicly stated mission of the modern pharmaceutical industry is to relentlessly cure disease and alleviate human suffering. However, its underlying financial architecture actively demands the exact opposite. From a strictly economic perspective, curing a patient permanently eradicates a reliable, paying customer. Consequently, the world's most powerful medical conglomerates have aggressively ...